RegendoGEL™ is a bioresorbable hydrogel system used to stimulate the tooth’s own healing processes. This is the first and only hydrogel-based product that uses natural tooth derived bioactive molecules to induce dental pulp regeneration. Its biocompatibility, non-inflammatory, and degradable properties reverse the degenerative cycle of tooth decay.
RegendoGEL offers several advantages over traditional pulp therapies such as pulpotomy and root canal treatment. It allows for the preservation of the natural tooth structure, eliminates the need for artificial materials, and promotes continued root development in immature teeth.
RegendoGEL has not yet been cleared by the FDA and is not available for sale at this time in the US.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.regendodent.com
Regendodent Questions
Regendodent's website is https://www.regendodent.com
Regendodent's LinkedIn profile is https://www.linkedin.com/company/regendodent
Regendodent has
1 employees.
View email and phone details for 1
employees at Regendodent.
Regendodent's industry is
Medical Equipment Manufacturing
Regendodent's top competitors are
Novagyn,
Geneneer,
Xenotherapeutics,
Quincy Public Schools,
Cytotheryx, Inc.,
Ohsu Knight Cancer Institute,
Demeetra,
Bioars Therapeutics S.a.,
Dio Tree,
Phycin.
Regendodent's categories are Medical Equipment Manufacturing
Regendodent's founding year is 2022
